Tapioca dextrin fiber
A soluble dietary fiber made from tapioca (cassava) starch that is partially resistant to digestion; used to add fiber, bind, and improve texture with minimal sweetness.
Should I eat Tapioca dextrin fiber?
A refined but generally well‑tolerated soluble fiber from tapioca that helps boost fiber intake with little taste or sweetness. Most people do fine at typical amounts, but large servings can cause digestive discomfort, and it shouldn’t replace fiber‑rich whole foods.
Summary
Tapioca dextrin fiber is a non‑digestible, soluble carbohydrate produced from cassava starch and accepted by FDA as a dietary fiber. Human studies show it can improve bowel regularity and may reduce post‑meal blood sugar when it replaces digestible carbs in foods, with some preliminary evidence of improved insulin resistance in type 2 diabetes. Regulatory reviews indicate low toxicological concern. Tolerance is usually good up to about 45 g/day, though gas and loose stools can occur at higher or quickly increased intakes. Quality and fiber content vary by supplier and by syrup versus powder, so label details matter.
Key Research Benefits
Key Research Risks
Overview
What is it?
Why is it used?
Origin
Dextrins have been made for over a century by gently roasting starch with a small amount of acid to form shorter, re-linked chains. In the 1990s–2000s, manufacturers refined these methods to create ‘resistant dextrin’—a version that resists digestion and behaves like soluble fiber. Cassava (tapioca) became a popular source because it is naturally gluten-free and widely grown across Thailand, Vietnam, and Brazil, providing neutral flavor and consistent starch quality.
Process: Acid heat conversion, transglycosylation, purification
Steps
Chemicals
Research & Safety
Research Summary
Digestive Effects
Human data suggest most adults tolerate resistant dextrin up to about 45 g/day, but comfort varies by person and dose. Common side effects at higher intakes are gas, bloating, mild cramping, and loose stools. Starting with small amounts (for example, 3–10 g/day) and increasing gradually often improves tolerance. People with sensitive digestion (e.g., IBS) may need smaller, divided servings and time to adapt. Adequate hydration helps any fiber work better and may reduce cramping.
Limit Consumption
Healthy adults generally tolerate tapioca dextrin fiber well at typical serving sizes. People with IBS or other sensitive GI conditions may experience symptoms at lower doses and should increase intake slowly. In people with type 2 diabetes, replacing digestible carbs with resistant dextrin can modestly blunt post‑meal glucose and may aid insulin resistance in small trials, but products vary and this is not a substitute for medical care. Use in infant and toddler foods is regulated by category, and it is not a routine infant fiber source. Regulatory and toxicology reviews (GRAS; ADI “not specified”) indicate low toxicological concern at food-use levels.
Fact Sheet
Regulatory Status
ESG & Sustainability
Allergens and Diet
Natural Alternatives
Oat fiber
Inulin (chicory root fiber)
Resistant starch (tapioca)
Citations
GRAS Notice GRN 1045 Agency Response Letter – Resistant dextrin from tapioca
2022-08-15FDA CFSAN • FDA
GRAS Notice GRN 1170 Agency Response Letter – Resistant dextrin from tapioca
2024-10-22FDA CFSAN • FDA
Dextrins—white and yellow (INS 1400): ADI not specified
1982-01-01JECFA • JECFA
Modified Starches Monograph (includes INS 1400 dextrin)
2014-01-01FAO/JECFA • FAO/JECFA
Nutriose®06 and reduction of post-prandial glycaemic responses
2014-10-08EFSA NDA Panel • EFSA Journal
Questions and Answers on Dietary Fiber
2024-07-25FDA CFSAN • FDA
Resistant dextrin as a prebiotic improves insulin resistance and inflammation in women with type 2 diabetes: a randomised controlled trial
2015-07-01Aliasgharzadeh A., et al. • British Journal of Nutrition
Effects of resistant maltodextrin on bowel movements: a systematic review and meta-analysis
2018-02-13Watanabe N., et al. • Clinical and Experimental Gastroenterology
Impact of a Resistant Dextrin on Intestinal Ecology
2012-01-01Lefranc-Millot C., et al. • SAGE / Journal of International Medical Research
GRAS Notice 1045 Dossier (manufacturing description and specs)
2022-08-15Anderson Global Group • FDA